January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
March 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
February 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.21 billion in 2025 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
December 2025
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 7.25 billion in 2025 with a CAGR of 12.17%.
October 2025
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 62.86 billion by 2034, at a CAGR of 7.27%.
July 2025
The global next-generation cancer therapeutics market size was evaluated at USD 86.20 billion in 2024 and is predicted to hit around USD 175.20 billion by 2034, growing at a CAGR of 7.35%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
June 2025
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
March 2025
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.36 billion in 2024 and is expected to hit around USD 9.53 billion by 2034, growing at a CAGR of 5.92%.
February 2025
The lung cancer therapeutics market size is valued at USD 35.37 billion in 2025 and is expected to hit around USD 76.65 billion by 2035, growing at a CAGR of 8.04%.
January 2025
The global cancer therapeutics and biotherapeutics market size was valued at USD 194.15 billion in 2024 and is expected to hit around USD 440.59 billion by 2034, growing at a CAGR of 8.54%.
May 2026
The global melanoma therapeutics market size accounted for USD 7.39 billion in 2025 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
May 2026
The global microbiome therapeutics market size is evaluated at USD 250.06 million in 2025 and is predicted to hit around USD 4,120.15 million by 2035, with a CAGR of 32.34%.
May 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 19.16 billion in 2025, with a CAGR of 9.25%.
May 2026
The global multiple sclerosis therapeutics market size was evaluated at USD 34.80 billion in 2025 and is predicted to hit around USD 66.80 billion by 2035, growing at a CAGR of 6.90%.
May 2026
The pancreatic cancer market size was estimated at USD 3.25 billion in 2025 and it is expected to be hit around USD 11.47 billion by 2035 at a CAGR of 13.44%.
May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 3.84 billion in 2025, at a CAGR of 9.02%.
May 2026
The mRNA therapeutics market size was valued at USD 20.83 billion in 2025 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
May 2026
The global amyloid beta therapeutics market size was evaluated at USD 5.20 billion in 2025 and is predicted to hit around USD 26.50 billion by 2035, growing at a CAGR of 17.80%.
May 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
May 2026
The global cancer biological therapy market size is expected to increase from USD 124.44 billion in 2025 and is predicted to reach at USD 266.75 billion by 2035, with a solid CAGR of 7.99%.
May 2026
The global lung cancer surgery market size was evaluated at USD 1.55 billion in 2025 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
May 2026
The global tau protein targeting therapeutics market size was evaluated at USD 1,100.00 million in 2025 and is predicted to hit around USD 6,534.16 million by 2035, growing at a CAGR of 19.50%.
May 2026
The global CAR-T therapies for blood cancers market size was evaluated at USD 6.80 billion in 2025 and is predicted to hit around USD 38.40 billion by 2035, growing at a CAGR of 18.90%.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
April 2026
The global cancer monoclonal antibodies market size reached USD 125.10 billion in 2025 and is predicted to hit around USD 658.07 billion by 2035, with a solid CAGR of 18.06%.
April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.09 billion in 2025, with a CAGR of 11.14%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
April 2026
The global esophageal cancer market size is estimated to hit around USD 36.51 billion by 2035 increasing from USD 16.65 billion in 2025, with a CAGR of 8.17%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com